CompanyTrack
B

BIOSCRIPT HOLDINGS LIMITED

Active Macclesfield

Activities of other holding companies n.e.c.

239 employees Website
Life sciences and medical technology Activities of other holding companies n.e.c.
B

BIOSCRIPT HOLDINGS LIMITED

Activities of other holding companies n.e.c.

Founded 16 Feb 2021 Active Macclesfield, England 239 employees bioscriptgroup.com
Life sciences and medical technology Activities of other holding companies n.e.c.
Accounts Submitted 30 Jun 2025
Confirmation Statement Submitted
Net assets £-31.62M £9.26M 2024 year on year
Total assets £0.00 £51.05M 2024 year on year
Total Liabilities £-40.07M £113.49M 2024 year on year
Charges None No charges registered

AI Analysis

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Registered Address

Suite A, Greenway House Larkwood Way Tytherington Business Park Macclesfield SK10 2XR England

Office (Macclesfield)

Nether Alderley, Macclesfield SK10 4EL

Office (UK)

The Ropewalks Newton Street Macclesfield Cheshire SK11 6QJ

Office (USA)

103 Carnegie Center Suite 300 Princeton, NJ 08540 6235

Credit Report

Discover BIOSCRIPT HOLDINGS LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2021–2024)

Cash in Bank

£4.75M

Increased by £3.24M (+214%)

Net Assets

-£31.62M

Decreased by £9.26M (-41%)

Total Liabilities

-£40.07M

Decreased by £113.49M (-155%)

Turnover

£28.07M

Decreased by £26.21k (-0%)

Employees

239

Decreased by 3 (-1%)

Debt Ratio

N/A

Decreased by 144 (-100%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

11 Allotments 117,098 Shares £19510.06m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
26 Apr 20241,682£900k£535.077
29 Sept 20223,867£115k£29.84
29 Sept 20223,907£37k£9.56
8 Apr 20225,870£16593.74m£2.83m
8 Apr 20222,436£54.71m£22k

Officers

Officers

4 active 5 resigned
Status
Andrew John MedleyDirectorBritishEngland582 Mar 2021Active
Gabrielle Alison SilverDirectorBritishEngland5220 Sept 2022Active
James MaxwellDirectorBritishUnited Kingdom4115 Feb 2024Active
Jill HarrisonDirectorBritishEngland522 Mar 2021Active

Shareholders

Shareholders (66)

Victoria Morgan
0.1%
15428 Feb 2025
Trevor Stokes
0.0%
528 Feb 2025
Tom Wilding
0.0%
428 Feb 2025

Persons with Significant Control

Persons with Significant Control (2)

2 Active

Sovereign Capital Partners Llp

United Kingdom

Active
Notified 16 Feb 2021
Nature of Control
  • Significant Influence Or Control

Bb Shelf 4 Llp

United Kingdom

Active
Notified 16 Feb 2021
Nature of Control
  • Ownership Of Shares 75 To 100 Percent
  • Voting Rights 75 To 100 Percent
  • Right To Appoint And Remove Directors

Group Structure

Group Structure

BB SHELF 4 LLP united kingdom voting rights 75 to 100 percent limited liability partnership
BIOSCRIPT HOLDINGS LIMITED Current Company
BIOSCRIPT MIDCO 1 LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

Charges

Charges

No charges registered

Documents

Company Filings

DateCategoryDescriptionDocument
17 Jul 2025CapitalCapital Return Purchase Own SharesView(4 pages)
30 Jun 2025AccountsAnnual accounts made up to 2024-09-30View(48 pages)
16 Jun 2025CapitalCapital Return Purchase Own SharesView(4 pages)
16 Jun 2025CapitalCapital Cancellation SharesView(15 pages)
9 Jun 2025ResolutionResolutionsView(1 page)
17 Jul 2025 Capital

Capital Return Purchase Own Shares

30 Jun 2025 Accounts

Annual accounts made up to 2024-09-30

16 Jun 2025 Capital

Capital Return Purchase Own Shares

16 Jun 2025 Capital

Capital Cancellation Shares

9 Jun 2025 Resolution

Resolutions

Recent Activity

Latest Activity

Capital Return Purchase Own Shares

7 months ago on 17 Jul 2025

Annual accounts made up to 2024-09-30

7 months ago on 30 Jun 2025

Capital Return Purchase Own Shares

8 months ago on 16 Jun 2025

Capital Cancellation Shares

8 months ago on 16 Jun 2025

Resolutions

8 months ago on 9 Jun 2025